COVID-19
Dear Authors,
a large number of reviewers in Europe and particularly in Italy, are clinicians: their commitment in the current public health emergency is aimed at helping and treating...
Articles published in the Oncology Reviews are Open Access, giving a number of advantages for the widest dissemination, visibility, and impact of your research.
Publishing as Open access offers authors a number of benefits, including:
Copyright on any article in the Oncology Reviews is retained by the author(s) under a CC BY-NC license, which permits to copy, redistribute, remix, transform, and build upon the material in any non-commercial medium or format. This type of license is mandatory for many research funding bodies, and allows for maximum dissemination and re-use of open access materials.
Manuscripts are evaluated by skilled reviewers who are authorities in your field. Our journal follows the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA).
Article level metrics for each article show your research impact on the journal site and provide understandings in the ways people interact with your research in the online environment.
Dear Authors,
a large number of reviewers in Europe and particularly in Italy, are clinicians: their commitment in the current public health emergency is aimed at helping and treating...